Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Hanover Insurance Group (THG) is a Top Dividend Stock Right Now: Should You Buy?
Hanover Insurance Group (THG) is a Top Dividend Stock Right Now: Should You Buy?

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent

Why 1st Source (SRCE) is a Great Dividend Stock Right Now
Why 1st Source (SRCE) is a Great Dividend Stock Right Now

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is

4 Consumer Product Stocks Showing Resilience Amid Market Headwinds
4 Consumer Product Stocks Showing Resilience Amid Market Headwinds

Companies within the Zacks Consumer Products – Staples industry are navigating a challenging consumer environment. Rising living costs are straining household budgets, prompting more cautious

WEX or V: Which Is the Better Value Stock Right Now?
WEX or V: Which Is the Better Value Stock Right Now?

Investors interested in Financial Transaction Services stocks are likely familiar with Wex (WEX) and Visa (V). But which of these two stocks presents investors with the better value opportunity

BGC or MKTX: Which Is the Better Value Stock Right Now?
BGC or MKTX: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Financial - Investment Bank sector have probably already heard of BGC Group (BGC) and MarketAxess (MKTX). But which of these two stocks presents investors

EPAM vs. CSGP: Which Stock Is the Better Value Option?
EPAM vs. CSGP: Which Stock Is the Better Value Option?

Investors interested in stocks from the Computers - IT Services sector have probably already heard of Epam (EPAM) and CoStar Group (CSGP). But which of these two companies is the best option for

WF vs. ITUB: Which Stock Is the Better Value Option?
WF vs. ITUB: Which Stock Is the Better Value Option?

Investors with an interest in Banks - Foreign stocks have likely encountered both Woori Bank (WF) and Banco Itau (ITUB). But which of these two stocks presents investors with the better value

PHIN or MOD: Which Is the Better Value Stock Right Now?
PHIN or MOD: Which Is the Better Value Stock Right Now?

Investors with an interest in Automotive - Original Equipment stocks have likely encountered both Phinia (PHIN) and Modine (MOD). But which of these two stocks presents investors with the better

Kroger Q2 Earnings Beat, E-commerce Sales Jump, FY25 Outlook Raised
Kroger Q2 Earnings Beat, E-commerce Sales Jump, FY25 Outlook Raised

The Kroger Co. KR reported second-quarter fiscal 2025 results that outpaced earnings expectations, while sales came below the Zacks Consensus Estimate. The performance was driven by strength in

Can On-Demand's Popularity Continue to Help SEZL Pay Dividends?
Can On-Demand's Popularity Continue to Help SEZL Pay Dividends?

Sezzle SEZL launched On-Demand to provide users with a flexible option to Pay-in-4 wherever Visa is accepted. This strategy succeeded in removing constraints on its direct merchant partnerships

Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report?
Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report?

A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost about 16.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue

Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?
Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Theravance Biopharma (TBPH). Shares have added about 9.8% in that time frame, outperforming the S&P 500.

But investors have to be wondering

Why Is H&R Block (HRB) Up 0.6% Since Last Earnings Report?
Why Is H&R Block (HRB) Up 0.6% Since Last Earnings Report?

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price

Intel Chips Excel in AI Benchmark: Will it Boost Prospects?
Intel Chips Excel in AI Benchmark: Will it Boost Prospects?

Intel Corporation INTC recently announced that its GPU systems have successfully achieved MLPerf v5.1 benchmark requirements. MLPerf Inference v5.1 is the newest release of an industry-standard AI

BOK Financial Gains 16% in 3 Months: How to Play the Stock Now?
BOK Financial Gains 16% in 3 Months: How to Play the Stock Now?

BOK Financial Corporation BOKF shares have gained 16% in the past three months, outperforming the industry’s growth of 9.2%. Meanwhile, BOKF peers Cullen/Frost Bankers, Inc. CFR and First Horizon

Fabrinet vs. TE Connectivity: Which Electronics Stock is the Better Buy?
Fabrinet vs. TE Connectivity: Which Electronics Stock is the Better Buy?

Both Fabrinet FN and TE Connectivity TEL play vital roles as contract manufacturers in the electronics and industrial markets. Fabrinet is best known for high-precision optical components and

Jobless Claims Come in Highest in Almost Four Years
Jobless Claims Come in Highest in Almost Four Years

Pre-market futures are up at this hour, breaking higher following this morning’s economic data. These happen to be important reports: Consumer Price Index (CPI) and Weekly Jobless Claims. Taken

Agnico Eagle Increases Investment in Maple Through Private Placement
Agnico Eagle Increases Investment in Maple Through Private Placement

Agnico Eagle Mines Limited AEM has announced an increase in its investment in Maple Gold Mines Ltd. through a non-brokered private placement at a price of $0.60 per unit, for a total consideration

Visa Stock Drops Under 200-Day SMA: Buy, Hold or Cut the Card?
Visa Stock Drops Under 200-Day SMA: Buy, Hold or Cut the Card?

Visa Inc. V shares have been losing steam in recent months, slipping below key technical thresholds and signaling a bearish turn in sentiment. On Sept. 10, 2025, the stock closed at $338.12, moving

Can NextEra's Battery Storage Drive a Sustainable Clean Energy Future?
Can NextEra's Battery Storage Drive a Sustainable Clean Energy Future?

NextEra Energy NEE is advancing on its clean energy transition by pairing renewable generation with increasing battery storage. While solar and wind remain vital components of its portfolio, the

AVGO's Semiconductor Sales Growth Picks Up: A Sign of More Upside?
AVGO's Semiconductor Sales Growth Picks Up: A Sign of More Upside?

Broadcom’s AVGO Semiconductor revenues are benefiting from strong demand for XPUs, which are a type of application-specific integrated circuit (ASIC) necessary to train Generative AI (Gen AI)

O vs. VICI: Who Wins the Dividend Race, and Which Stock to Buy?
O vs. VICI: Who Wins the Dividend Race, and Which Stock to Buy?

Dividend income remains a cornerstone for income-focused investors, and within the REIT space, Realty Income O and VICI Properties VICI are two leading names. Both have built reputations as reliable

NIO Stock Falls 9% on $1B Equity Offering Plan: Time to Buy the Dip?
NIO Stock Falls 9% on $1B Equity Offering Plan: Time to Buy the Dip?

NIO Inc. NIO tumbled 8.9% yesterday to close at $5.72, after the company announced a $1 billion equity offering. The Chinese electric vehicle (EV) maker intends to sell roughly 182 million shares of

Circle Drops 30% in a Month: Should You Still Hold the CRCL Shares?
Circle Drops 30% in a Month: Should You Still Hold the CRCL Shares?

Circle Internet Group CRCL shares have dropped 30.3% in the past month, underperforming both the Zacks Financial-Miscellaneous Services industry and the Zacks Finance sector. While the industry has

TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA
TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA

Travere Therapeutics TVTX announced that the FDA, following further review of the supplemental new drug application (sNDA) for Filspari (sparsentan) in focal segmental glomerulosclerosis ("FSGS")